Application of biomarkers to clinical trials in systemic sclerosis.
about
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentThe ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.
P2860
Application of biomarkers to clinical trials in systemic sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Application of biomarkers to clinical trials in systemic sclerosis.
@ast
Application of biomarkers to clinical trials in systemic sclerosis.
@en
type
label
Application of biomarkers to clinical trials in systemic sclerosis.
@ast
Application of biomarkers to clinical trials in systemic sclerosis.
@en
prefLabel
Application of biomarkers to clinical trials in systemic sclerosis.
@ast
Application of biomarkers to clinical trials in systemic sclerosis.
@en
P2860
P1476
Application of biomarkers to clinical trials in systemic sclerosis.
@en
P2093
Robert Lafyatis
P2860
P2888
P356
10.1007/S11926-011-0216-4
P577
2012-02-01T00:00:00Z